• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Bio Products Laboratory - Articles and news items

Coagadex available in the UK for patients with hereditary factor X deficiency

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency…

BPL’s Coagadex approved in the EU for hereditary factor X deficiency

Industry news / 30 March 2016 / Victoria White

Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency…

FDA approves Coagadex for hereditary Factor X deficiency

Industry news / 21 October 2015 / Victoria White

Until this orphan drug approval, no specific coagulation factor replacement therapy was available in the US for patients with hereditary Factor X deficiency…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +